Edition:
India

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Capital Market

3.34USD
23 Oct 2020
Change (% chg)

$0.04 (+1.21%)
Prev Close
$3.30
Open
$3.33
Day's High
$3.36
Day's Low
$3.25
Volume
2,680
Avg. Vol
17,576
52-wk High
$7.62
52-wk Low
$2.15

All Insider Trades
Trading Date Name Title Type Shares Traded Price
2 Sep 2020

Clarke (John K.)

Director Sell 7,260 $4.01
28 Aug 2020

Clarke (John K.)

Director Sell 100 $4.00
27 Aug 2020

Clarke (John K.)

Director Sell 5,440 $4.09
26 Aug 2020

Clarke (John K.)

Director Sell 2,200 $4.30
19 Jun 2020

Shukla (Sanjay S M.D.)

Chief Executive Officer Buy 6,000 $4.27
19 Jun 2020

Broadfoot (Jill Marie)

Chief Financial Officer Buy 1,850 $4.22
20 May 2020

Denyes (Nancy)

General Counsel Sell 322 $3.62
20 May 2020

Schimmel (Paul R Ph.D.)

Director Sell 8,447 $3.64
16 May 2020

Denyes (Nancy)

General Counsel Buy 892 $0.00
10 Feb 2020

Schimmel (Paul R Ph.D.)

Director Buy 254,000 $4.25
7 Feb 2020

Broadfoot (Jill Marie)

Chief Financial Officer Sell 375 $4.03
7 Feb 2020

Shukla (Sanjay S M.D.)

Chief Executive Officer Sell 745 $4.03
6 Feb 2020

Broadfoot (Jill Marie)

Chief Financial Officer Buy 893 $0.00
6 Feb 2020

Shukla (Sanjay S M.D.)

Chief Executive Officer Buy 1,786 $0.00
17 May 2019

Krueger (Nancy)

General Counsel Sell 4,651 $0.45
16 May 2019

Krueger (Nancy)

General Counsel Buy 12,500 $0.00
12 Apr 2019

Schimmel (Paul R Ph.D.)

Director Buy 1,848,428 $0.54
21 Dec 2018

Mendlein (John D)

Director Buy 195,000 $0.42
20 Dec 2018

Mendlein (John D)

Director Buy 50,000 $0.41
26 Nov 2018

Schimmel (Paul R Ph.D.)

Director Buy 147,225 $0.54

Institutional Holders

% Shares Owned: 63.68%
# of Holders: 36
Total Shares Held: 6,373,106
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

John Clarke

66 2005 Independent Chairman of the Board

Sanjay Shukla

47 2017 President, Chief Executive Officer, Director

Jill Broadfoot

58 2018 Chief Financial Officer

Nancy Denyes

52 2019 General Counsel and Corporate Secretary

Timothy Coughlin

53 2017 Independent Director

Jane Gross

63 2019 Independent Director

Jeffrey Hatfield

62 2017 Independent Director

Svetlana Lucas

2019 Independent Director

Paul Schimmel

79 2005 Independent Director